Acomplia
Description
Acomplia know as well as rimonabant is an anti-obesity drug. It was approved for marketing in the European Union in June 2006. Acomplia is not yet approved for use in the United States, where it is known as Zimulti.
Current medication is the first in a new class of therapeutic agents called Cannabinoid-1 Receptor Blockers (CB1) destined to treat obesity and related conditions.
Acomplia is used complementary to diet and exercise to treat obese or overweight patients who suffer from Type 2 diabetes and abnormal levels of fat in the blood. Sometimes current medication can prevent the risk of cardiovascular disease.
Recommendations
Consult your doctor before taking current medications and follow his instructions about dosage for your current condition.
Precautions
To get full precautions list we advice you to contact your healthcare provider to get all the detailed information.
Ingredients
Active ingredient: rimonabant.
